MINNEAPOLIS, October 27, 2015 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today that the Company’s new GLUCOCARD Shine blood glucose monitoring system has been selected by HME Business Magazine as the 2015 outstanding new product in the diabetic supply category. The HME Business New Product Awards honors outstanding product development achievements by manufacturers that service the home medical equipment sector.

“We are honored to have the GLUCOCARD Shine, our newest blood glucose monitoring system, recognized for this award,” said ARKRAY USA President Jonathan Chapman. “We at ARKRAY are dedicated to providing people with diabetes accurate and reliable devices that help them better manage their disease. The GLUCOCARD Shine is a prime example of that dedication.”

Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to juvenile diabetes). People with untreated diabetes typically experience frequent urination, become increasingly thirsty and hungry. The ADA estimates that more than 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of American’s 65 years of age or greater will develop diabetes.


About ARKRAY USA, Inc.

ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit